> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Medtronic’s Symplicity for Hypertension Approved
- URL: https://www.fdaweb.com/medtronics-symplicity-for-hypertension-approved/
- Published: 2023-11-20T12:00:00.000Z
- Updated: 2026-09-14T14:16:40.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5155831

FDA has approved a Medtronic PMA for its Symplicity Spyral renal denervation system for treating hypertension. The device works by delivering radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood pressure. The therapy is administered by catheter in the artery leading to the kidney. “Once the tube is in place, the doctor administers energy to the system to calm the excessive activity of the nerves connected to the kidney,” the company says. “The Symplicity blood pressure procedure is a promising treatment option for clinicians and patients alike and offers opportunity to fulfill a significant unmet need in hypertension care, especially for those patients who are desperately seeking additional approaches to get their blood pressure down.”